alpha-aminopyridine has been researched along with Thromboembolism in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Hakeem, M; Abrams, CS; Alanio, C; Apostolidis, SA; Baxter, AE; Belman, J; Chen, Z; Dougherty, J; Dunbar, D; Frank, I; Giannini, HM; Giles, JR; Goel, RR; Gouma, S; Greenplate, AR; Hensley, SE; Huang, AC; Huang, YJ; Ittner, CAG; Kuthuru, O; Manne, S; Mathew, D; Meyer, NJ; Oldridge, DA; Pattekar, A; Poncz, M; Rauova, L; Reilly, JP; Sarkar, A; Suzuki, A; Vella, LA; Weiderhold, B; Weisman, AR; Wherry, EJ; Wu, JE; Zhao, L | 1 |
| Alfonso, F; Alvarado-Casas, T; Rivero, F; Salamanca, J; Vera, A | 1 |
2 other study(ies) available for alpha-aminopyridine and Thromboembolism
| Article | Year |
|---|---|
Signaling Through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19.
Topics: Adult; Aminopyridines; Blood Platelets; Cells, Cultured; Complement C5a; COVID-19; Female; Hospitalization; Humans; Male; Morpholines; Platelet Activation; Pyrimidines; Receptor, Anaphylatoxin C5a; Receptors, IgG; SARS-CoV-2; Severity of Illness Index; Signal Transduction; Syk Kinase; Thromboembolism | 2022 |
Coronary Plaque Erosion after Abemaciclib Treatment Onset: An Unknown Side Effect?
Topics: Aged; Aminopyridines; Antineoplastic Agents; Artifacts; Benzimidazoles; Breast Neoplasms; Coronary Vessels; Enoxaparin; Female; Humans; Lipids; Myocardial Infarction; Protein Kinase Inhibitors; Thromboembolism; Ticagrelor; Treatment Outcome | 2021 |